222 related articles for article (PubMed ID: 37598369)
1. Design, optimization, production and activity testing of recombinant immunotoxins expressed in plants and plant cells for the treatment of monocytic leukemia.
Knödler M; Frank K; Kerpen L; Buyel JF
Bioengineered; 2023 Dec; 14(1):2244235. PubMed ID: 37598369
[TBL] [Abstract][Full Text] [Related]
2. Plant-made immunotoxin building blocks: A roadmap for producing therapeutic antibody-toxin fusions.
Knödler M; Buyel JF
Biotechnol Adv; 2021; 47():107683. PubMed ID: 33373687
[TBL] [Abstract][Full Text] [Related]
3. Comparison of microbial and transient expression (tobacco plants and plant-cell packs) for the production and purification of the anticancer mistletoe lectin viscumin.
Gengenbach BB; Keil LL; Opdensteinen P; Müschen CR; Melmer G; Lentzen H; Bührmann J; Buyel JF
Biotechnol Bioeng; 2019 Sep; 116(9):2236-2249. PubMed ID: 31140580
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of an Anti-CD7 Recombinant Immunotoxin Based on PE24 in CHO and
Krebs SK; Stech M; Jorde F; Rakotoarinoro N; Ramm F; Marinoff S; Bahrke S; Danielczyk A; Wüstenhagen DA; Kubick S
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430170
[TBL] [Abstract][Full Text] [Related]
5. Designing the furin-cleavable linker in recombinant immunotoxins based on Pseudomonas exotoxin A.
Weldon JE; Skarzynski M; Therres JA; Ostovitz JR; Zhou H; Kreitman RJ; Pastan I
Bioconjug Chem; 2015 Jun; 26(6):1120-8. PubMed ID: 25997032
[TBL] [Abstract][Full Text] [Related]
6. Generation of Potent Anti-HER1/2 Immunotoxins by Protein Ligation Using Split Inteins.
Pirzer T; Becher KS; Rieker M; Meckel T; Mootz HD; Kolmar H
ACS Chem Biol; 2018 Aug; 13(8):2058-2066. PubMed ID: 29920062
[TBL] [Abstract][Full Text] [Related]
7. Preproricin expressed in Nicotiana tabacum cells in vitro is fully processed and biologically active.
Tagge EP; Chandler J; Harris B; Czako M; Marton L; Willingham MC; Burbage C; Afrin L; Frankel AE
Protein Expr Purif; 1996 Aug; 8(1):109-18. PubMed ID: 8812841
[TBL] [Abstract][Full Text] [Related]
8. Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.
Salvatore G; Beers R; Margulies I; Kreitman RJ; Pastan I
Clin Cancer Res; 2002 Apr; 8(4):995-1002. PubMed ID: 11948105
[TBL] [Abstract][Full Text] [Related]
9. Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems.
Rosenberg Y; Sack M; Montefiori D; Forthal D; Mao L; Hernandez-Abanto S; Urban L; Landucci G; Fischer R; Jiang X
PLoS One; 2013; 8(3):e58724. PubMed ID: 23533588
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Hydra HALT-1 as a toxin moiety for recombinant immunotoxin.
Jiemy WF; Hiew LF; Sha HX; In LLA; Hwang JS
BMC Biotechnol; 2020 Jun; 20(1):31. PubMed ID: 32552895
[TBL] [Abstract][Full Text] [Related]
11. From gene to harvest: insights into upstream process development for the GMP production of a monoclonal antibody in transgenic tobacco plants.
Sack M; Rademacher T; Spiegel H; Boes A; Hellwig S; Drossard J; Stoger E; Fischer R
Plant Biotechnol J; 2015 Oct; 13(8):1094-105. PubMed ID: 26214282
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the influence of common antibiotics on the efficacy of a recombinant immunotoxin in tissue culture.
Zhu Y; Weldon JE
BMC Res Notes; 2019 May; 12(1):293. PubMed ID: 31133049
[TBL] [Abstract][Full Text] [Related]
13. Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial Design.
Müller F; Cunningham T; Liu XF; Wayne AS; Pastan I
Clin Cancer Res; 2016 Oct; 22(19):4913-4922. PubMed ID: 27114443
[TBL] [Abstract][Full Text] [Related]
14. Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.
Tur MK; Huhn M; Thepen T; Stöcker M; Krohn R; Vogel S; Jost E; Osieka R; van de Winkel JG; Fischer R; Finnern R; Barth S
Cancer Res; 2003 Dec; 63(23):8414-9. PubMed ID: 14679004
[TBL] [Abstract][Full Text] [Related]
15. Production of a tumour-targeting antibody with a human-compatible glycosylation profile in N. benthamiana hairy root cultures.
Lonoce C; Salem R; Marusic C; Jutras PV; Scaloni A; Salzano AM; Lucretti S; Steinkellner H; Benvenuto E; Donini M
Biotechnol J; 2016 Sep; 11(9):1209-20. PubMed ID: 27313150
[TBL] [Abstract][Full Text] [Related]
16. Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody.
Sainsbury F; Sack M; Stadlmann J; Quendler H; Fischer R; Lomonossoff GP
PLoS One; 2010 Nov; 5(11):e13976. PubMed ID: 21103044
[TBL] [Abstract][Full Text] [Related]
17. Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies.
Guillaume T; Dehame V; Chevallier P; Peterlin P; Garnier A; Grégoire M; Pichinuk E; Rubinstein DB; Wreschner DH
Exp Hematol; 2019 Feb; 70():97-108. PubMed ID: 30593830
[TBL] [Abstract][Full Text] [Related]
18. Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes.
Stahnke B; Thepen T; Stöcker M; Rosinke R; Jost E; Fischer R; Tur MK; Barth S
Mol Cancer Ther; 2008 Sep; 7(9):2924-32. PubMed ID: 18790773
[TBL] [Abstract][Full Text] [Related]
19. Antibody internalization after cell surface antigen binding is critical for immunotoxin development.
Kuo SR; Alfano RW; Frankel AE; Liu JS
Bioconjug Chem; 2009 Oct; 20(10):1975-82. PubMed ID: 19785403
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking β-1,2-xylose and core α-1,3-fucose.
Jansing J; Sack M; Augustine SM; Fischer R; Bortesi L
Plant Biotechnol J; 2019 Feb; 17(2):350-361. PubMed ID: 29969180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
